BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27103042)

  • 1. Aging Kidney Transplantation.
    Musso CG; Giordani MC; Imperiali N
    Rev Invest Clin; 2016; 68(2):68-74. PubMed ID: 27103042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomere shortening and cellular senescence in a model of chronic renal allograft rejection.
    Joosten SA; van Ham V; Nolan CE; Borrias MC; Jardine AG; Shiels PG; van Kooten C; Paul LC
    Am J Pathol; 2003 Apr; 162(4):1305-12. PubMed ID: 12651622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year.
    Benigni A; Bruzzi I; Mister M; Azzollini N; Gaspari F; Perico N; Gotti E; Bertani T; Remuzzi G
    Kidney Int; 1999 Feb; 55(2):674-85. PubMed ID: 9987092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney.
    Melk A; Schmidt BM; Takeuchi O; Sawitzki B; Rayner DC; Halloran PF
    Kidney Int; 2004 Feb; 65(2):510-20. PubMed ID: 14717921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence limits regenerative capacity and allograft survival.
    Braun H; Schmidt BM; Raiss M; Baisantry A; Mircea-Constantin D; Wang S; Gross ML; Serrano M; Schmitt R; Melk A
    J Am Soc Nephrol; 2012 Sep; 23(9):1467-73. PubMed ID: 22797186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of reduced functioning mass to chronic kidney allograft dysfunction in rats.
    Heemann UW; Azuma H; Tullius SG; Mackenzie H; Brenner BM; Tilney NL
    Transplantation; 1994 Dec; 58(12):1317-22. PubMed ID: 7528948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathologic characteristics of early or late acute cellular rejection and outcome after kidney transplant.
    Wu K; Budde K; Schmidt D; Neumayer HH; Rudolph B
    Exp Clin Transplant; 2014 Aug; 12(4):314-22. PubMed ID: 25095709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic renal allograft dysfunction: risk factors, immunology and prevention.
    Fadili W; Habib Allah M; Laouad I
    Arab J Nephrol Transplant; 2013 Jan; 6(1):45-50. PubMed ID: 23282234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal dysfunction and intragraft proMMP9 activity in renal transplant recipients with interstitial fibrosis and tubular atrophy.
    Racca MA; Novoa PA; Rodríguez I; Della Vedova AB; Pellizas CG; Demarchi M; Donadio AC
    Transpl Int; 2015 Jan; 28(1):71-8. PubMed ID: 25179305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Replicative senescence in kidney aging, renal disease, and renal transplantation.
    Naesens M
    Discov Med; 2011 Jan; 11(56):65-75. PubMed ID: 21276412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetuin-A pretransplant serum levels, kidney allograft function and rejection episodes: a 3-year posttransplantation follow-up.
    Roos M; Heinemann FM; Lindemann M; Horn PA; Lutz J; Stock K; Thürmel K; Baumann M; Witzke O; Heemann U
    Kidney Blood Press Res; 2011; 34(5):328-33. PubMed ID: 21613794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UNOS renal transplant registry.
    Cecka JM
    Clin Transpl; 2001; ():1-18. PubMed ID: 12211771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-transplant hypertension: a major risk factor for chronic progressive renal allograft dysfunction?
    Frei U; Schindler R; Wieters D; Grouven U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1995; 10(7):1206-11. PubMed ID: 7478125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-bet-positive mononuclear cell infiltration is associated with transplant glomerulopathy and interstitial fibrosis and tubular atrophy in renal allograft recipients.
    Yadav B; Prasad N; Agrawal V; Jain M; Agarwal V; Jaiswal A; Bhadauria D; Sharma RK; Gupta A
    Exp Clin Transplant; 2015 Apr; 13(2):145-51. PubMed ID: 25871366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic allograft nephropathy or interstitial fibrosis and tubular atrophy: what is in a name?
    Haas M
    Curr Opin Nephrol Hypertens; 2014 May; 23(3):245-50. PubMed ID: 24626060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restorative and rejection-associated lymphangiogenesis after renal transplantation: friend or foe?
    Vass DG; Hughes J; Marson LP
    Transplantation; 2009 Dec; 88(11):1237-9. PubMed ID: 19996921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Functional loss of the transplanted kidney: immunological and non-immunological factors].
    Cattaneo D; Perico N; Remuzzi G
    G Ital Nefrol; 2004; 21 Suppl 26():S28-33. PubMed ID: 15732041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfiltration, creatinine clearance and chronic graft loss.
    Heaf JG; Ladefoged J
    Clin Transplant; 1998 Feb; 12(1):11-8. PubMed ID: 9541417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic utility of deceased donor implantation biopsy in determining function and graft survival after kidney transplantation.
    Cockfield SM; Moore RB; Todd G; Solez K; Gourishankar S
    Transplantation; 2010 Mar; 89(5):559-66. PubMed ID: 20110855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic renal allograft injury: early detection, accurate diagnosis and management.
    Pascual J; Pérez-Sáez MJ; Mir M; Crespo M
    Transplant Rev (Orlando); 2012 Oct; 26(4):280-90. PubMed ID: 22902496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.